Mondelez (MDLZ) Offering Possible 8.7% Return Over the Next 28 Calendar Days

view original post

Mondelez’s most recent trend suggests a bullish bias. One trading opportunity on Mondelez is a Bull Put Spread using a strike $63.00 short put and a strike $58.00 long put offers a potential 8.7% return on risk over the next 28 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $63.00 by expiration. The full premium credit of $0.40 would be kept by the premium seller. The risk of $4.60 would be incurred if the stock dropped below the $58.00 long put strike price.

The 5-day moving average is moving up which suggests that the short-term momentum for Mondelez is bullish and the probability of a rise in share price is higher if the stock starts trending.

The 20-day moving average is moving up which suggests that the medium-term momentum for Mondelez is bullish.

The RSI indicator is at 79.22 level which suggests that the stock is neither overbought nor oversold at this time.

To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here


LATEST NEWS for Mondelez

UPDATE 2-Mondelez, CVS postpone back-to-office plans as Omicron spreads
Wed, 22 Dec 2021 09:45:11 +0000
Oreo cookies maker Mondelez International Inc and drug-store chain CVS Health joined a growing list of U.S. firms to put off their return-to-office plans as COVID-19 cases surge across the country due to the fast-spreading Omicron variant. A Mondelez spokesperson said “concern and uncertainty” caused by the Omicron variant has led the company to postpone the planned reopening of its global headquarters in West Fulton Market, Chicago to a later date from Jan. 10. CVS has also decided to delay plans for its U.S. corporate employees to return to a hybrid work format on Jan. 10, spokesperson Erin Shields Britt said in an e-mailed statement.

Mondelez, CVS postpone back-to-office plans as Omicron spreads
Wed, 22 Dec 2021 08:56:59 +0000
(Reuters) -Oreo cookies maker Mondelez International Inc and drug-store chain CVS Health joined a growing list of U.S. firms to put off their return-to-office plans as COVID-19 cases surge across the country due to the fast-spreading Omicron variant. A Mondelez spokesperson said “concern and uncertainty” caused by the Omicron variant has led the company to postpone the planned reopening of its global headquarters in West Fulton Market, Chicago to a later date from Jan. 10. CVS has also decided to delay plans for its U.S. corporate employees to return to a hybrid work format on Jan. 10, spokesperson Erin Shields Britt said in an e-mailed statement.

11 neglected stocks that may rise at least 20% in 2022: BofA
Fri, 17 Dec 2021 17:17:58 +0000
Looking to buy some stocks in the New Year? Here are 11 names to consider from Bank of America.

The Post-Fed Relief Rally Lasted a Day. What Next.
Fri, 17 Dec 2021 11:45:00 +0000
Biden’s social spending bill needs more time to pass, CDC panel says pick Pfizer and Moderna over J&J vaccine, Oracle said to be in talks to buy Cerner, and other news to start your day.

Mondelez International Inc (MDLZ) EVP and President, Europe Vinzenz P. …
Thu, 16 Dec 2021 05:15:03 +0000
EVP and President, Europe of Mondelez International Inc (30-Year Financial, Insider Trades) Vinzenz P.

Be Sociable, Share!

Related Posts